DV Biomed Co., Ltd. - Laporan Laba Rugi (TTM)

DV Biomed Co., Ltd.
TW ˙ TPEX
Laporan Laba Rugi (TTM)

Laporan Laba Rugi DV Biomed Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,811 1,812 1,828 1,845 1,836 1,827 1,843 1,859 1,863 1,866 1,569 1,272 945 619 1,500 1,462 574 643 713
Change (%) 0.03 0.92 0.92 -0.49 -0.49 0.88 0.87 0.19 0.19 -15.92 -18.93 -25.68 -34.54 142.39 -2.56 -60.76 12.12 10.81
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 921 886 867 848 827 805 811 817 822 827 653 479 307 135 773 772 149 175 201
Change (%) -3.78 -2.13 -2.18 -2.56 -2.63 0.76 0.75 0.62 0.62 -21.04 -26.65 -35.86 -55.91 470.39 -0.16 -80.68 17.37 14.80
% of Revenue 50.86 48.92 47.43 45.98 45.02 44.05 44.00 43.95 44.14 44.33 41.63 37.67 32.51 21.90 51.52 52.79 25.99 27.21 28.19
Gross Operating Profit 890 926 961 997 1,010 1,022 1,032 1,042 1,041 1,039 916 793 638 483 727 690 425 468 512
Change (%) 3.98 3.85 3.71 1.27 1.26 0.97 0.96 -0.16 -0.16 -11.84 -13.43 -19.52 -24.25 50.44 -5.11 -38.48 10.28 9.32
% of Revenue 49.14 51.08 52.57 54.02 54.98 55.95 56.00 56.05 55.86 55.67 58.37 62.33 67.49 78.10 48.48 47.21 74.01 72.79 71.81
SG&A 654 626 619 611 601 591 600 609 624 639 579 520 423 326 564 550 310 368 426
Change (%) -4.38 -1.16 -1.17 -1.65 -1.68 1.49 1.47 2.50 2.44 -9.35 -10.32 -18.61 -22.87 72.96 -2.54 -43.69 18.82 15.93
% of Revenue 36.14 34.54 33.83 33.13 32.74 32.35 32.55 32.74 33.49 34.25 36.92 40.84 44.72 52.70 37.61 37.61 53.98 57.20 59.85
R&D 55 32 21 11 12 12 12 12 13 13 12 12 10 8 11 11 5 5 5
Change (%) -42.06 -33.11 -49.50 7.63 7.09 -0.77 -0.77 2.41 2.36 -3.95 -4.11 -15.11 -17.80 39.26 -7.26 -50.47 -5.32 -5.62
% of Revenue 3.04 1.76 1.17 0.58 0.63 0.68 0.67 0.66 0.67 0.69 0.79 0.93 1.06 1.33 0.77 0.73 0.92 0.78 0.66
OpEx 1,631 1,544 1,507 1,471 1,440 1,409 1,423 1,438 1,459 1,479 1,245 1,011 740 470 1,348 1,332 464 548 632
Change (%) -5.31 -2.38 -2.44 -2.11 -2.15 1.05 1.04 1.43 1.41 -15.84 -18.83 -26.75 -36.52 186.97 -1.21 -65.17 18.08 15.37
% of Revenue 90.04 85.22 82.43 79.69 78.40 77.09 77.22 77.35 78.31 79.27 79.34 79.44 78.29 75.93 89.90 91.14 80.89 85.19 88.69
Operating Income 180 268 321 375 397 419 420 421 404 387 324 262 205 149 152 130 110 95 81
Change (%) 48.37 19.97 16.65 5.87 5.54 0.30 0.30 -4.07 -4.24 -16.21 -19.34 -21.52 -27.42 1.75 -14.51 -15.40 -13.11 -15.41
% of Revenue 9.96 14.78 17.57 20.31 21.60 22.91 22.78 22.65 21.69 20.73 20.66 20.56 21.71 24.07 10.10 8.86 19.11 14.81 11.31
Interest Expense -6 -5 -4 -2 -3 -4 -6 -7 -6 -5 -4 -3 -2 -0 -7 -7 -2 -2 -2
Change (%) -13.51 -26.72 -36.47 50.07 33.36 27.16 21.36 -12.06 -13.72 -21.94 -28.11 -47.08 -89.99 4,480.00 0.80 -76.52 19.14 16.06
% of Revenue -0.30 -0.26 -0.19 -0.12 -0.18 -0.24 -0.31 -0.37 -0.32 -0.28 -0.26 -0.23 -0.16 -0.03 -0.47 -0.49 -0.29 -0.31 -0.33
Net Income 251 301 279 257 281 305 310 316 299 281 270 259 211 163 113 63 89 71 52
Change (%) 20.06 -7.40 -7.99 9.30 8.51 1.91 1.88 -5.53 -5.85 -4.04 -4.21 -18.49 -22.69 -30.70 -44.29 41.63 -20.60 -25.94
% of Revenue 13.86 16.64 15.26 13.92 15.29 16.67 16.84 17.01 16.04 15.07 17.20 20.32 22.29 26.32 7.53 4.30 15.53 11.00 7.35

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista